Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

More on the ‘Game Changing’ Novartis Verdict
WSJ Online
Thursday, May 20, 2010 - 6:14am
tags:
Novartis, discrimination, lawsuits
ASCO's Abstract Release Day: Preview
TheStreet.com
Wednesday, May 19, 2010 - 7:07pm
tags:
oncology, cancer, ASCO, Celldex, Keryx, Delcath, Sunesis, Ziopharm, Pharmacyclics, OncoGenex
Getting Beyond The Corporate Culture At Pfizer
Forbes
Wednesday, May 19, 2010 - 7:06pm
tags:
Pfizer, generics, corporate culture
J&J Scandal Hearing May Be Postponed
Pharmalot
Wednesday, May 19, 2010 - 6:17pm
tags:
JNJ, recalls
Who's Going to Get What in the $250M Novartis Sex Discrimination Verdict
BNET Pharma
Wednesday, May 19, 2010 - 6:12pm
tags:
Novartis, lawsuits, discrimination
Orphan Status for Allos Drug
Yahoo/Zacks.com
Wednesday, May 19, 2010 - 6:10pm
tags:
Allos, orphan drugs, Pralatrexate, bladder cancer
Teva gets OK to market generic Lipitor in Canada
Yahoo/AP
Wednesday, May 19, 2010 - 6:09pm
tags:
Teva Pharmaceuticals, generics, Lipitor, Canada, Pfizer
A Potential Blockbuster Bites the Dust. Should You Worry?
Motley Fool
Wednesday, May 19, 2010 - 6:08pm
tags:
Biogen Idec, ocrelizumab, Roche, rheumatoid arthritis
Pharma execs expect fines, M&A and easier credit
Fierce Pharma
Wednesday, May 19, 2010 - 5:02pm
tags:
M&A, fines, credit rating
St. Jude's and Glaxo Find Early Clues to Potential Malaria Drugs
WSJ Online
Wednesday, May 19, 2010 - 4:56pm
tags:
St. Jude Medical, GSK
GlaxoSmithKline Cutting Prices to Gain Market Share in China
Seeking Alpha
Wednesday, May 19, 2010 - 4:46pm
tags:
GSK, China, India
Novartis disputes sex discrimination claims
Marketwatch
Wednesday, May 19, 2010 - 4:42pm
tags:
Novartis, lawsuits, discrimination
Is the “Big” in Big Pharma a value creator or liability?
Pharmareform
Wednesday, May 19, 2010 - 11:34am
tags:
Big Pharma
Californians Challenge Pay-To-Delay Deals
Pharmalot
Wednesday, May 19, 2010 - 11:33am
tags:
California, pay-for-delay, Bayer, Barr Laboratories, Teva Pharmaceuticals, Cipro
Abbott Labs gets FDA approval for new blood test
Yahoo/AP
Wednesday, May 19, 2010 - 11:25am
tags:
FDA, Abbott Laboratories, Prism Chagas
Big Pharma's Romance With Biotech Still Smolders, Despite Its Cold Shoulder to OSI
BNET Pharma
Wednesday, May 19, 2010 - 11:20am
tags:
OSI Pharmaceuticals, Big Pharma, Astellas, Roche, Gilead Sciences, CV Therapeutics
Pfizer Strengthens Pipeline With Ergonex Pharma's Terguride
Yahoo/Zacks.com
Wednesday, May 19, 2010 - 11:19am
tags:
Terguride, Pfizer, PAH, Ergonex
Vanda Schizophrenia Drug Gets Rotten Review
TheStreet.com
Wednesday, May 19, 2010 - 11:05am
tags:
Vanda, Fanapt, schizophrenia, Titan, Novartis
Javelin shares plunge as Discovery's on the rise
Marketwatch
Wednesday, May 19, 2010 - 11:03am
tags:
Javelin, Discovery Labs, Hospira, Dyloject
Discovery Labs jumps on FDA update
Marketwatch
Wednesday, May 19, 2010 - 10:38am
tags:
Discovery Labs, FDA, Surfaxin

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.